Risk for hospital readmission following bariatric surgery.

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22

Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP. Ann Surg (2013) 1.45

A novel risk scoring system reliably predicts readmission after pancreatectomy. J Am Coll Surg (2015) 1.43

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract (2013) 1.40

The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol (2012) 1.04

The relationship between duration of stay and readmissions in patients undergoing bariatric surgery. Surgery (2015) 0.94

General and vascular surgery readmissions: a systematic review. J Am Coll Surg (2014) 0.88

Society of Anesthesia and Sleep Medicine Guidelines on Preoperative Screening and Assessment of Adult Patients With Obstructive Sleep Apnea. Anesth Analg (2016) 0.81

A validated, risk assessment tool for predicting readmission after open ventral hernia repair. Hernia (2015) 0.81

Predictors of readmission after laparoscopic gastric bypass and sleeve gastrectomy: a comparative analysis of ACS-NSQIP database. Surg Endosc (2015) 0.80

30-Day readmission after bariatric surgery in a publicly funded regionalized center of excellence system. Surg Endosc (2015) 0.77

Early hospital readmission after bariatric surgery. Surg Endosc (2015) 0.76

Readmission Following Laparoscopic Sleeve Gastrectomy. JSLS (2016) 0.75

Impact of care coaching on hospital length of stay, readmission rates, postdischarge phone calls, and patient satisfaction after bariatric surgery. Surg Obes Relat Dis (2016) 0.75

Validation of an integrative mathematical model of dehydration and rehydration in virtual humans. Physiol Rep (2016) 0.75

Surgeon case volume and readmissions after laparoscopic Roux-en-Y gastric bypass: more is less. Surg Endosc (2016) 0.75

Preventing Returns to the Emergency Department FollowingBariatric Surgery. Obes Surg (2017) 0.75

Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34

Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91

Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75

Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med (2009) 8.06

Trends in bariatric surgical procedures. JAMA (2005) 5.67

Meta-analysis: surgical treatment of obesity. Ann Intern Med (2005) 5.17

Healthcare utilization and outcomes after bariatric surgery. Med Care (2006) 2.92

Hospital complication rates with bariatric surgery in Michigan. JAMA (2010) 2.92

Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr (1992) 2.62

Hospitalization before and after gastric bypass surgery. JAMA (2005) 2.12

Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med (2009) 2.02

Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis (2009) 1.93

A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg (2009) 1.64

Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis (2010) 1.40

Development and validation of a bariatric surgery morbidity risk calculator using the prospective, multicenter NSQIP dataset. J Am Coll Surg (2011) 1.33

Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg (2006) 1.21

Relationship between surgeon and hospital volume and readmission after bariatric operation. J Am Coll Surg (2007) 1.20

One-year readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass. Obes Surg (2008) 1.19

Laparoscopic versus open gastric bypass for morbid obesity: a multicenter, prospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Ann Surg (2006) 1.12

Relationship between provider volume and postoperative complications for bariatric procedures in New York State. J Am Coll Surg (2006) 1.10

Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg (2004) 1.09

Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient. Ann Surg (2012) 0.98

Bariatric surgery outcomes in the elderly: an ACS NSQIP study. J Gastrointest Surg (2011) 0.95

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature (2005) 11.12

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med (2005) 8.86

Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg (2003) 6.50

Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med (2002) 4.27

Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med (2002) 4.11

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA (2013) 3.49

Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog (2009) 3.35

Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog (2010) 3.28

Vaccination in humans generates broad T cell cytokine responses. J Immunol (2004) 3.27

A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet (2008) 3.25

A study on the economic impact of bariatric surgery. Am J Manag Care (2008) 2.83

Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.82

Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science (2009) 2.64

Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med (2011) 2.64

HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat Med (2003) 2.62

CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J Virol (2005) 2.41

Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One (2012) 2.33

Whither or wither microbicides? Science (2008) 2.17

Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.09

Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol (2005) 2.01

The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet (2002) 1.99

Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. J Virol (2010) 1.98

Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis (2009) 1.93

Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J Virol (2003) 1.92

Alcohol volume, drinking pattern, and cardiovascular disease morbidity and mortality: is there a U-shaped function? Am J Epidemiol (2002) 1.91

A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. J Virol (2010) 1.84

High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol (2009) 1.82

A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest (2007) 1.79

Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med (2002) 1.76

Development of a framework and coding system for modifications and adaptations of evidence-based interventions. Implement Sci (2013) 1.72

Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol (2008) 1.69

The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol (2005) 1.67

The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J Virol (2002) 1.60

The reliability and validity of discrete and continuous measures of psychopathology: a quantitative review. Psychol Bull (2011) 1.60

Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest (2004) 1.56

Laparoscopic gastric bypass surgery: current technique. J Laparoendosc Adv Surg Tech A (2003) 1.56

Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest (2014) 1.54

A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J Virol (2004) 1.53

An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge. Vaccine (2012) 1.52

Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. J Virol (2011) 1.52

Myeloid dendritic cells isolated from tissues of SIV-infected Rhesus macaques promote the induction of regulatory T cells. AIDS (2012) 1.50

The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest (2012) 1.50

Measuring central airway obstruction. What do bronchoscopists do? Ann Am Thorac Soc (2015) 1.49

Detection of antigen-specific T cell interferon gamma expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques. J Immunol Methods (2003) 1.47

Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant. J Infect Dis (2013) 1.47

Gastrointestinal complications of laparoscopic Roux-en-Y gastric bypass surgery: clinical and imaging findings. Radiology (2002) 1.46

Feasibility of retinoids for the treatment of emphysema study. Chest (2006) 1.45

Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr (2011) 1.45

Response to the Center for Medicare & Medicaid Services coverage with evidence development request for primary prevention implantable cardioverter-defibrillators: data from the OMNI study. Heart Rhythm (2012) 1.40

Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord (2005) 1.38

Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts (2008) 1.37

Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis (2008) 1.37

Topical anesthetics for dermatologic procedures: a review. Dermatol Surg (2012) 1.37

With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus. J Virol (2008) 1.36

Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob Res (2007) 1.32

The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes Surg (2012) 1.30

Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. J Virol (2004) 1.30

Relations of cotinine and carbon monoxide to self-reported smoking in a cohort of smokers and ex-smokers followed over 5 years. Nicotine Tob Res (2002) 1.29

Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study. J Am Acad Dermatol (2012) 1.27

Lithogenic risk factors in the morbidly obese population. J Urol (2008) 1.26

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.23

Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239. J Immunol (2007) 1.21

Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med (2004) 1.19

Increased adipose protein carbonylation in human obesity. Obesity (Silver Spring) (2011) 1.18

Small-sample performance of the robust score test and its modifications in generalized estimating equations. Stat Med (2005) 1.18

Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg (2008) 1.16

Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies. J Virol (2013) 1.16

Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23-26 weeks' gestational age at a tertiary center. Pediatrics (2004) 1.15

Relations of serotonin function to personality: current views and a key methodological issue. Psychiatry Res (2006) 1.15

Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials. Am J Respir Crit Care Med (2006) 1.14

Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS (2013) 1.14

Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity. J Virol (2010) 1.14

Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms. J Invest Dermatol (2004) 1.13

Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg (2010) 1.13

SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma. AIDS Res Hum Retroviruses (2011) 1.13

The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PLoS One (2012) 1.12

A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J (2012) 1.11

Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J Infect Dis (2004) 1.11

TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure. J Virol (2011) 1.11

The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest (2003) 1.11

Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef. J Virol (2005) 1.10

Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol (2012) 1.09

Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg (2005) 1.08

Motivational interviewing to enhance nicotine patch treatment for smoking cessation among homeless smokers: a randomized controlled trial. Addiction (2013) 1.08

Characterization of virus-responsive plasmacytoid dendritic cells in the rhesus macaque. Clin Diagn Lab Immunol (2005) 1.08

Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg (2007) 1.08

TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells. Proc Natl Acad Sci U S A (2009) 1.07

Effects of ovarian steroids on immunoglobulin-secreting cell function in healthy women. Clin Diagn Lab Immunol (2003) 1.07

Collaborative assessment of California spiny lobster population and fishery responses to a marine reserve network. Ecol Appl (2012) 1.07

Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res (2007) 1.05